[Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D010974:Platelet Aggregation / Q000187:drug effects*; D012008:Recurrence; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
La prevenzione secondaria della cardiopatia ischemica con farmaci antiaggreganti piastrinici nel paziente post-infartuato. Rassegna sintetica.